argenx to Acquire Unnatural Products, Adding Peptide Discovery Engine to Broaden Immunology Capabilities
FROM THE WIRE · MANILATIMES.NET
Pairs Unnatural Products’ (UNP) peptide expertise with argenx's antibody engineering, expanding the ways to target novel biologyExtends argenx’s immunology innovation to more patients, with the potential for oral and long-acting medicines Builds on more than two years of…
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralMid-size biotech acquisition valued up to about $1.15 billion, relevant but not systemic.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01argenx will acquire all remaining shares of Unnatural Products, Inc.
- 02The transaction values UNP at up to approximately $1.15 billion.
- 03UNP will continue operating from Santa Cruz with its current team.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets